1. Equipped with more nano-scaled textures, the nanoLOCK up-regulates more osteogenic and angiogenic growth factors that provide for bone growth and fusion.
2. The nanoLOCK surface is part of Titan Spine’s Endoskeleton line of interbody fusion implants.
3. Mr. Sevey will spearhead the education about and demonstration of the nanoLOCK surface, as well as relay the scientific evidence behind the technology.
4. Titan Spine President, Kevin Gemas, said the first of Mr. Sevey’s jobs will be to differentiate the nanoLOCK surface from other companies that have nanotechnology, yet to be FDA-cleared.
5. Mr. Sevey previously held the position of manager and biomaterials technical specialist at Synthes/DePuy Biomaterials. His role involved clinical and technical consulting and education surgeons and residents among other responsibilities.
“The spine industry is beginning to recognize ‘nanotechnology’ as more than a marketing concept and now as a design approach,” said Barbara Boyan, PhD, Dean of the School of Engineering at Virginia Commonwealth University and author of studies supporting Titan Spine. “Titan Spine has been at the forefront of this charge for nearly a decade…”
More articles on devices:
5 things to know about Cartiva’s $8.5M financing
Considerable growth in the 2D X-Ray equipment market by 2021: 5 key points
21 new device launches & releases — June 22, 2015
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
